# DALIRESP
> **NDA022522** · New Drug Application · Sponsor: ASTRAZENECA · Approved 2011-02-28
## Drug
- **FDA Application Number:** NDA022522
- **Application type:** New Drug Application
- **Brand name:** DALIRESP
- **Generic name:** ROFLUMILAST
- **Active ingredients:** ROFLUMILAST
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASTRAZENECA
- **Manufacturer:** AstraZeneca Pharmaceuticals LP
- **First approval:** 2011-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022522)
---
*AI Analytics · CC0 1.0*